Spruce Biosciences's total assets for Q1 2026 were $56.17M, an increase of 5.93% from the previous quarter. SPRB total liabilities were $21.52M for the fiscal quarter, a 104.84% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.